Emerging Microbes & Infections

Article	Citations
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan	2110
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes	1285
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody	982
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients	875
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors	764
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2	584
Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia	581
Laboratory diagnosis of emerging human coronavirus infections – the state of the art	543
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension	468
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26	454
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak	408
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists	386
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients	371
Identification of novel mobile colistin resistance gene mcr-10	315
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity	308
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)	292
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses	277
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells	266
ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens	266
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron	265
COVID-19 pandemic – an African perspective	265
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost	263
Clinical observation and management of COVID-19 patients	261
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient	250
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction	249

Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2	241
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies	232
The different clinical characteristics of corona virus disease cases between children and their families in China – the character of children with COVID-19	232
A serological survey of SARS-CoV-2 in cat in Wuhan	223
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients	208
Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation	205
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells	192
SARS-CoV-2 infection, disease and transmission in domestic cats	188
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study	187
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic	175
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection	168
Patterns of IgG and IgM antibody response in COVID-19 patients	160
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species	144
Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity	142
Antibody titres decline 3-month post-vaccination with BNT162b2	137
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review	126
Thein vitroantiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor	121
Risks and features of secondary infections in severe and critical ill COVID-19 patients	121
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine	119
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection	115
High neutralizing antibody titer in intensive care unit patients with COVID-19	114
Antibodies in the breast milk of a maternal woman with COVID-19	112
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates	110
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East	108
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells	107
Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020	107
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)	106
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)	104
Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets	100
Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infection	97
Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2	97
Susceptibility of rabbits to SARS-CoV-2	96
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease	92
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture	90
Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies	88
Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae	88
Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing	87
Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods	86
Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters	85
Serological differentiation between COVID-19 and SARS infections	82
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2	79
Diagnostic value and key features of computed tomography in Coronavirus Disease 2019	77
The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan	77
Susceptibility of swine cells and domestic pigs to SARS-CoV-2	74
Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity	73
The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections	71
Timely development of vaccines against SARS-CoV-2	71
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus	70
Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients	68
Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022	67

Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study	67
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	65
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine	64
Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned	61
Social distancing: how religion, culture and burial ceremony undermine the effort to curb COVID-19 in South Africa	61
Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008–2018	61
A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners	60
Emergence of ST11-K47 and ST11-K64 hypervirulent carbapenem-resistant Klebsiella pneumoniae in bacterial liver abscesses from China: a molecular, biological, and epidemiological study	60
Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19	58
Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines	57
Deficiency of HIF-1α enhances influenza A virus replication by promoting autophagy in alveolar type II epithelial cells	57
Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population	55
Co-existence of a novel plasmid-mediated efflux pump with colistin resistance gene mcr in one plasmid confers transferable multidrug resistance in Klebsiella pneumoniae	55
Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer	54
Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine	54
Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression	53
Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19	53
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies	53
Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system	53
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?	50
Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation	50
Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals	50
African swine fever control and prevention: an update on vaccine development	50
Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients	50
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates	49
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission	49
Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study	48
Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model	48
Animal models for emerging coronavirus: progress and new insights	47
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities	47
Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family cluster	46
Zoonotic and reverse zoonotic events of SARS-CoV-2 and their impact on global health	46
Perception of the 2020 SARS-CoV-2 pandemic among medical professionals in Germany: results from a nationwide online survey	45
High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study	45
Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture	45
Global dissemination of H5N1 influenza viruses bearing the clade 2.3.4.4b HA gene and biologic analysis of the ones detected in China	44
Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis	44
Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion	43
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates	43
Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach	43
The interplay between emerging human coronavirus infections and autophagy	42
Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries	42
Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge	41
Identification of novel tetracycline resistance gene tet(X14) and its co-occurrence with tet(X2) in a tigecycline-resistant and colistin-resistant Empedobacter stercoris	41
Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019	41
Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target	41
Emerging colistin resistance inSalmonella entericaserovar Newport isolates from human infections	41
Evolution and extensive reassortment of H5 influenza viruses isolated from wild birds in China over the past decade	40
Experimental re-infected cats do not transmit SARS-CoV-2	40
Excretion of SARS-CoV-2 through faecal specimens	40
Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents	40
Mathematic modeling of COVID-19 in the United States	40
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2	39
Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor	39
Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin	39
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue	39
Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications	39
Metformin attenuated sepsis-related liver injury by modulating gut microbiota	39
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection	38
Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study	38
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial	38
Novel H5N6 reassortants bearing the clade 2.3.4.4b HA gene of H5N8 virus have been detected in poultry and caused multiple human infections in China	38
An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics	37
Plasma miRNA profile at COVID-19 onset predicts severity status and mortality	37
The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing	37
Clostridioides difficile infection in the Asia-Pacific region	37
Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells	37
Comparative pathogenicity and environmental transmission of recent highly pathogenic avian influenza H5 viruses	37
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants	36
Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong	36
Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort	36
Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing	36
Advances in detection of infectious agents by aptamer-based technologies	36
Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018	36
A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques	36
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster	35
HIV-1 did not contribute to the 2019-nCoV genome	35
A novel SARS-CoV-2 related coronavirus with complex recombination isolated from bats in Yunnan province, China	35
Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents	35
Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study	35

Penaeidins restrict white spot syndrome virus infection by antagonizing the envelope proteins to block viral entry	35
Loss of orf3b in the circulating SARS-CoV-2 strains	35
Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China	34
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan	34
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis	34
Cytotoxin-producing Klebsiella oxytoca in the preterm gut and its association with necrotizing enterocolitis	34
Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site	33
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV	33
Susceptibility of livestock to SARS-CoV-2 infection	33
Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections	33
Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors	33
An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants	33
SARS-CoV-2 reinfection and COVID-19 severity	32
Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens	31
No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2	31
The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract	31
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response	31
Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study	31
Low incidence of airborne SARS-CoV-2 in acute care hospital rooms with optimized ventilation	31
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection	31
Confirmation of fifth Candida auris clade by whole genome sequencing	30
Impact of population movement on the spread of 2019-nCoV in China	30
Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China	30
Viral loads in throat and anal swabs in children infected with SARS-CoV-2	30
Tropism, pathology, and transmission of equine parvovirus-hepatitis	30
Swine acute diarrhea syndrome coronavirus-induced apoptosis is caspase- and cyclophilin D- dependent	30
Public’s early response to the novel coronavirus–infected pneumonia	30
Infections with highly pathogenic avian influenza A virus (HPAIV) H5N8 in harbor seals at the German North Sea coast, 2021	29
Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma	29
Cointegration as a mechanism for the evolution of a KPC-producing multidrug resistance plasmid in Proteus mirabilis	29
L-lysine potentiates aminoglycosides against Acinetobacter baumannii via regulation of proton motive force and antibiotics uptake	28
Alarming situation of emerging H5 and H7 avian influenza and effective control strategies	28
The type I-E CRISPR-Cas system influences the acquisition of blaKPC-IncF plasmid in Klebsiella pneumonia	28
ATP-binding cassette (ABC) import systems of Mycobacterium tuberculosis: target for drug and vaccine development	28
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay	28
Mapping the global potential transmission hotspots for severe fever with thrombocytopenia syndrome by machine learning methods	28
Antibodies to SARS-CoV-2 in dogs and cats, USA	28
Tick-borne encephalitis foci in northeast Italy revealed by combined virus detection in ticks, serosurvey on goats and human cases	28
Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis	27
Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays	27
The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China	27
Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study	27
Wild boar harbouring African swine fever virus in the demilitarized zone in South Korea, 2019	27
Modelling Toxoplasma gondii infection in human cerebral organoids	27
Isolation and characterization of a duck-origin goose astrovirus in China	26
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants	26
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study	26
Methicillin-resistant Staphylococcus aureus in China: a multicentre longitudinal study and whole-genome sequencing	26
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response	26
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France	25
Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model	25
Trypsin promotes porcine deltacoronavirus mediating cell-to-cell fusion in a cell type-dependent manner	25
Possible recombination between two variants of concern in a COVID-19 patient	25
Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection	25
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models	25
Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19	24
Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry	24
Increased temperatures reduce the vectorial capacity of Aedes mosquitoes for Zika virus	24
Genomic epidemiology of emerging ESBL-producing Salmonella Kentucky blaCTX-M-14b in Europe	24
Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021	24
Backtracking and forward checking of human listeriosis clusters identified a multiclonal outbreak linked to Listeria monocytogenes in meat products of a single producer	24
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022	24
Increasing prevalence of hypervirulent ST5 methicillin susceptible Staphylococcus aureus subtype poses a serious clinical threat	24
Epidemiology and clinical course of COVID-19 in Shanghai, China	23
Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo	23
Prevalence of hypervirulent and carbapenem-resistant Klebsiella pneumoniae under divergent evolutionary patterns	23
mRNA and miRNA profiling of Zika virus-infected human umbilical cord mesenchymal stem cells identifies miR-142-5p as an antiviral factor	23
Omicron: a drug developer’s perspective	23
Identification of chicken CAR homology as a cellular receptor for the emerging highly pathogenic fowl adenovirus 4 via unique binding mechanism	23
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses	23
Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave	23
CRISPR-based platform for carbapenemases and emerging viruses detection using Cas12a (Cpf1) effector nuclease	22
Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant	22
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination	22
Molecular characterization, receptor binding property, and replication in chickens and mice of H9N2 avian influenza viruses isolated from chickens, peafowls, and wild birds in eastern China	22
Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern	22
Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China	22
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification	22
Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational study	21
Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China	21
Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness	21
Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants	21
Roles of lncRNAs in influenza virus infection	21
Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study	21
Saliva viral load better correlates with clinical and immunological profiles in children with coronavirus disease 2019	21
Balamuthia mandrillaris infection in China: a retrospective report of 28 cases	21
A porcine macrophage cell line that supports high levels of replication of OURT88/3, an attenuated strain of African swine fever virus	21
Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine	21
Comprehensive literature review of monkeypox	21
Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination	21
Compensatory effects of M. tuberculosis rpoB mutations outside the rifampicin resistance-determining region	20
Brucella melitensis, a latent “travel bacterium,” continual spread and expansion from Northern to Southern China and its relationship to worldwide lineages	20
Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococ	20
An IncP-2 plasmid sublineage associated with dissemination of blaIMP-45 among carbapenem-resistant Pseudomonas aeruginosa	20
Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients	20
Diagnosing Balamuthia mandrillaris encephalitis via next-generation sequencing in a 13-year-old girl	20
Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients	20
Human Borna disease virus 1 (BoDV-1) encephalitis cases in the north and east of Germany	20
Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study	20
Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR	20
SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner	20
Genetic manipulation of porcine deltacoronavirus reveals insights into NS6 and NS7 functions: a novel strategy for vaccine design	20
The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China	20
PB1 S524G mutation of wild bird-origin H3N8 influenza A virus enhances virulence and fitness for transmission in mammals	19
Jamestown Canyon virus in Massachusetts: clinical case series and vector screening	19
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis	19
Development of an automatic integrated gene detection system for novel severe acute respiratory syndrome-related coronavirus (SARS-CoV2)	19
A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice	19
PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255	19
Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques	19
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia	19
The potassium transporter KdpA affects persister formation by regulating ATP levels in Mycobacterium marinum	19
Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers	19
Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates	19
Misdiagnosis of imported falciparum malaria from African areas due to an increased prevalence of pfhrp2/pfhrp3 gene deletion: the Djibouti case	19
Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus	19